269 related articles for article (PubMed ID: 3875605)
1. Sch 34343, in-vitro antibacterial activity and beta-lactamase stability.
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():73-83. PubMed ID: 3875605
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the in-vitro antibacterial activity of Sch 34343.
Adam C; Naples L; Weiss W; Sabatelli F; Hare R; Loebenberg D; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():39-56. PubMed ID: 3875604
[TBL] [Abstract][Full Text] [Related]
3. Sch 34343: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Shannon K; King A; Phillips I
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():15-23. PubMed ID: 3897169
[TBL] [Abstract][Full Text] [Related]
4. In-vitro activity and beta-lactamase stability and inhibitory properties of a new penem antibiotic, Sch 34343.
Neu HC; Chin NX; Labthavikul P
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():25-37. PubMed ID: 3875603
[TBL] [Abstract][Full Text] [Related]
5. In-vitro evaluation of Sch 34343: antimicrobial activity, beta-lactamase stability and inhibition.
Jones RN; Barry AL; Fuchs PC; Thornsberry C
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():99-109. PubMed ID: 3875606
[TBL] [Abstract][Full Text] [Related]
6. beta-Lactamase susceptibility and comparative activity of Sch 34343 and other beta-lactams for non-fermenters, Neisseria spp. and beta-lactamase-positive Enterobacteriaceae.
Mouton RP; Mulders SL; van Gestel MH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():111-7. PubMed ID: 3928576
[TBL] [Abstract][Full Text] [Related]
7. MEN 10700, a new penem antibiotic: in-vitro activity and its correlation with beta-lactamase stability, PBP affinity and diffusion through the bacterial cell wall.
Fontana R; Altamura M; Arcamone F; Mazzariol A; Morandotti G; Sperning R; Cornaglia G
J Antimicrob Chemother; 1998 May; 41(5):513-25. PubMed ID: 9630405
[TBL] [Abstract][Full Text] [Related]
8. In-vitro evaluation of carumonam (Ro 17-2301).
Stobberingh EE; Houben AW; van Boven CP
J Antimicrob Chemother; 1986 Sep; 18(3):345-50. PubMed ID: 3490467
[TBL] [Abstract][Full Text] [Related]
9. In vitro antibacterial activity of Sch 34343 and its stability to beta-lactamases and renal dehydropeptidase 1.
Matsuda K; Sasaki K; Inoue K; Kondo H; Inoue M; Mitsuhashi S
Antimicrob Agents Chemother; 1985 Nov; 28(5):684-8. PubMed ID: 3879159
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of Sch 34343 against Gram-negative bacteria producing characterized beta-lactamases.
Dornbusch K; Frolander F; Cacciapuoti AF; Naples L; Hare RS; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():85-97. PubMed ID: 3897175
[TBL] [Abstract][Full Text] [Related]
11. Sch 34343 activity against streptococci and beta-lactam-resistant Enterobacteriaceae.
Gutmann L; Kitzis MD; Acar JF
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():147-54. PubMed ID: 3897168
[TBL] [Abstract][Full Text] [Related]
12. Antimicrobial activity and beta-lactamase stability of foramidocillin.
Mandell W; Neu HC
Antimicrob Agents Chemother; 1986 May; 29(5):769-73. PubMed ID: 3488017
[TBL] [Abstract][Full Text] [Related]
13. Gram-negative bacilli resistant to third-generation cephalosporins: beta-lactamase characterization and susceptibility to Sch 34343.
Medeiros AA; Hare R; Papa E; Adam C; Miller GH
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():119-32. PubMed ID: 3875602
[TBL] [Abstract][Full Text] [Related]
14. Comparative in vitro activity of CGP 31608, a new penem antibiotic.
Eliopoulos GM; Wennersten C; Reiszner E; Moellering RC
Antimicrob Agents Chemother; 1987 Aug; 31(8):1188-93. PubMed ID: 3498437
[TBL] [Abstract][Full Text] [Related]
15. In vitro antibacterial activity and beta-lactamase stability of CP-70,429 a new penem antibiotic.
Minamimura M; Taniyama Y; Inoue E; Mitsuhashi S
Antimicrob Agents Chemother; 1993 Jul; 37(7):1547-51. PubMed ID: 8363389
[TBL] [Abstract][Full Text] [Related]
16. Sch 29482: in-vitro antibacterial activity and susceptibility to beta-lactamases.
Phillips I; King A; Shannon K; Warren C
J Antimicrob Chemother; 1982 Feb; 9 Suppl C():25-30. PubMed ID: 6977532
[No Abstract] [Full Text] [Related]
17. Susceptibility of clinical isolates to expanded-spectrum beta-lactams alone and in the presence of beta-lactamase inhibitors.
Qadri SM; Ueno Y; Cunha BA
Chemotherapy; 1996; 42(5):334-42. PubMed ID: 8874972
[TBL] [Abstract][Full Text] [Related]
18. Beta-lactamases: current situation and clinical importance.
Garau J
Intensive Care Med; 1994 Jul; 20 Suppl 3():S5-9. PubMed ID: 7962990
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
Aktaş Z; Kayacan C; Oncul O
Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
[TBL] [Abstract][Full Text] [Related]
20. In-vitro activity of a new penem FCE 22101.
Hoban DJ
J Antimicrob Chemother; 1989 Mar; 23 Suppl C():53-7. PubMed ID: 2786518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
